Ginsenoside Rk3 ameliorates obesity-induced colitis.

PMID: 

J Agric Food Chem. 2024 Feb 14 ;72(6):2997-3007. Epub 2024 Feb 1. PMID: 38300824

Abstract Title: 

Ginsenoside Rk3 Ameliorates Obesity-Induced Colitis by Modulating Lipid Metabolism in C57BL/6 Mice.

Abstract: 

Lipid metabolism is closely related to obesity and its complications. Our previous study found that ginsenoside Rk3 (Rk3), a natural bioactive substance derived from ginseng, can effectively alleviate obesity-induced colitis, while its impact on the improvement of the lipid metabolism disorder remains unclear. Here, we demonstrated that Rk3 significantly alleviated inflammation, oxidative stress, and lipid dysregulation in high-fat diet-induced colitis C57BL/6 mice. The potential mechanism by which Rk3 mitigated colon inflammation in the context of obesity may involve the modulation of polyunsaturated fatty acid metabolism with specific attention to n-6 fatty acids, linoleic acid, and arachidonic acid. Rk3 intervention markedly reduced the production of pro-inflammatory factors (PGE2, PGD2, TXB2, HETE, and HODE) by inhibiting cyclooxygenase and lipoxygenase pathways, while enhancing the production of anti-inflammatory factors (EET and diHOME) via cytochrome P450 pathways. Our findings suggest that Rk3 is a potential anti-inflammatory natural drug that can improve obesity-induced intestinal inflammation by regulating lipid metabolism.

read more

#Ginsenoside #Rk3 #ameliorates #obesityinduced #colitis

Leave a comment

Know the various benefits of hibiscus kombucha20 hours ago How walnuts can boost your brain and memory13 hours ago Would you like to try ‘white pumpkin halva’?18 hours ago Why palm oil is harmful for you1 day ago Try these seeds to balance your hormones1 day ago